These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18660726)

  • 21. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
    Myers JS; Pierce J; Pazdernik T
    Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
    J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
    Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
    J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
    Saykin AJ; Ahles TA; McDonald BC
    Semin Clin Neuropsychiatry; 2003 Oct; 8(4):201-16. PubMed ID: 14613048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy.
    Mehlsen M; Pedersen AD; Jensen AB; Zachariae R
    Psychooncology; 2009 Mar; 18(3):248-57. PubMed ID: 18756583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the theory of unpleasant symptoms and the conceptual model of chemotherapy-related changes in cognitive function.
    Myers JS
    Oncol Nurs Forum; 2009 Jan; 36(1):E1-10. PubMed ID: 19136326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The (mis)classification of chemo-fog--methodological inconsistencies in the investigation of cognitive impairment after chemotherapy.
    Shilling V; Jenkins V; Trapala IS
    Breast Cancer Res Treat; 2006 Jan; 95(2):125-9. PubMed ID: 16261398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB; van Dam FS
    J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract]   [Full Text] [Related]  

  • 29. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients.
    Kayl AE; Meyers CA
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):24-8. PubMed ID: 16493256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
    Hermelink K; Küchenhoff H; Untch M; Bauerfeind I; Lux MP; Bühner M; Manitz J; Fensterer V; Münzel K
    Psychooncology; 2010 Dec; 19(12):1321-8. PubMed ID: 20127909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature.
    Jansen CE; Miaskowski C; Dodd M; Dowling G
    Oncol Nurs Forum; 2005 Mar; 32(2):329-42. PubMed ID: 15759070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
    Weis J; Poppelreuter M; Bartsch HH
    Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renaming "chemobrain".
    Hurria A; Somlo G; Ahles T
    Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
    Fan HG; Park A; Xu W; Yi QL; Braganza S; Chang J; Couture F; Tannock IF
    Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

  • 36. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
    Reid-Arndt SA
    Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
    Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
    Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.
    Cheung YT; Chui WK; Chan A
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):99-111. PubMed ID: 22015329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
    Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
    Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.